Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secukinumab regimen-finding study in active rheumatoid arthritis despite methotrexate
2010-024516-34Phase 2Completed
- Sponsor
- Novartis
- Start
- Jun 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of secukinumab in rheumatoid arthritis (RA) (3 arms), sponsored by Novartis. Primary endpoint: ACR20 response. Started Jun 2011; status: completed.
02
Drugs
secukinumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-024516-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024516-34.